lifestyle.nextmentors.com

Author: Whitehawk Therapeutics

Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026

April 19, 2026
Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series

April 16, 2026
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026

April 10, 2026
Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

March 17, 2026
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights

March 12, 2026
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

February 26, 2026
Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 18, 2026
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016

January 8, 2026
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer

December 1, 2025
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 27, 2025